US FDA approves combination chemotherapy Tagrisso

The US Food and Drug Administration has approved a combination of AstraZeneca’s blockbuster drug Tagrisso with chemotherapy to treat a type of lung cancer. The drug will be used to treat adults with an advanced form of lung cancer.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM